Aarey Drugs & Pharmaceuticals Ltd share price logo

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS

BSE: 524412

Small Cap

Pharma Sector

₹104.08

+0.19

(+0.18%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Aarey Drugs & Pharmaceuticals shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-23%

Searches for Aarey Drugs & Pharmaceuticals on INDmoney have decreased by 23% over the last 30 days.

Key Events for Aarey Drugs & Pharmaceuticals

Last Dividend Declared

₹0.10 per share, declared on 30/11/2018

View Dividend History

Aarey Drugs & Pharmaceuticals Stock Performance

as on October 10, 2026 at 5:14 am IST

  • Day's Low

    Day's High

    ₹100.54
    ₹105.70
    downward going graph

    3.40%

    Downside

    1.56%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹50.31
    ₹110.00
    downward going graph

    51.66%

    Downside

    5.69%

    Upside

    downward going graph

Aarey Drugs & Pharmaceuticals share price movements today

Previous Close
₹103.89
Open
₹102.01
Volume
1.52L
Upper Circuit
₹109.08
Lower Circuit
₹98.70
Day's Low - High
₹100.54 - ₹105.70
52 Week Low - High
₹50.31 - ₹110.00

Aarey Drugs & Pharmaceuticals Historical Returns

1 Month Return
+ 5.25 %
3 Month Return
+ 28.21 %
1 Year Return
+ 24.65 %
3 Year Return
+ 128.5 %
5 Year Return
+ 182.44 %

Aarey Drugs & Pharmaceuticals Fundamentals

as on October 9, 2026 at 11:44 pm IST

Market Cap

₹331.75 Cr

Return on Equity (ROE)

2.96

PE Ratio (TTM)

70.67

Return on capital employed (ROCE)

6.38

Industry PE ratio

51.89

Beta (LTM)

1.36

P/B Ratio

0.72

Dividend Yield

0

PEG Ratio

-7067.35

Quarterly Earnings Growth YOY

-25.55

EPS (TTM)

0

Book Value

0

Aarey Drugs & Pharmaceuticals Stock Valuation

as on October 9, 2026 at 11:44 pm IST

Aarey Drugs & Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (9.05x)

November 2, 2021

Industry (51.89x)

October 8, 2026

Today (70.67x)

October 8, 2026

Highest (78.15x)

November 6, 2025

LowHigh

Today’s Price to Earnings Ratio: 70.67x

Aarey Drugs & Pharmaceuticals Technical Analysis

Track how Aarey Drugs & Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish
Bullish11
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
0.35
Bullish
CCI (20)
-4.46
Neutral
RSI (14)
60.25
Neutral
Momentum (10)
1.67
Bullish
ADI (14)
24.69
Neutral
Ultimate Oscillator (7,14,28)
56.14
Neutral

Moving Averages

Name

Value

Action

SMA (20)
103.46
Bullish
EMA (20)
103.58
Bullish
VWMA (20)
103.73
Bullish
SMA (50)
103
Bullish
EMA (50)
103.18
Bullish
SMA (200)
102.52
Bullish
EMA (200)
102.7
Bullish
KAMA (200)
103.15
Bullish
DEMA (200)
102.89
Bullish

Aarey Drugs & Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aarey Drugs & Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA331.7536.49%0.004473
NA135.872.8%0.0010106
NA35.22-6.45%0.00167
NA268.1640.15%0.001095
NA1,150.5366.94%0.5846853

Aarey Drugs & Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
76.48
210.35
126.91
105.14
133.79
108.1
102.21
84.16
96.43
189.47
44.63
Other Income
0.29
5.14
1.58
0.02
0.68
7.54
1.55
0.79
4.18
-0.43
1.72
Total Income
76.77
215.49
128.49
105.16
134.47
115.64
103.76
84.95
100.61
189.04
46.34
Expenses
73.77
211.79
125.73
101.42
131.59
112.3
100.51
81.52
97.94
185.13
43.3
Operating Profit
2.71
-1.44
1.18
3.72
2.2
-4.2
1.7
2.64
-1.51
4.34
1.33
Operating Profit Margin %
3.54%
-0.68%
0.93%
3.54%
1.64%
-3.89%
1.66%
3.14%
-1.57%
2.29%
2.98%
Profit Before Interest, Tax and Depreciation
3
3.7
2.75
3.74
2.88
3.33
3.25
3.44
2.67
3.91
3.04
Interest
0.47
0.4
0.96
0.49
0.58
1.3
1.04
1.26
0.92
1.78
1.67
Depreciation
1.06
1.15
0.47
1.51
0.9
0.41
0.49
0.69
0.83
0.85
0.85
Profit Before Tax
1.47
2.15
1.32
1.74
1.4
1.62
1.72
1.49
0.92
1.28
0.52
Tax Paid
0.44
-0.01
0.09
0.15
0.68
1.16
0.36
0.46
0.35
-0.28
-0.51
Profit After Tax
1.02
2.15
1.24
1.6
0.72
0.47
1.37
1.02
0.57
1.56
1.02
Total Net profit including share of profit / Loss from associate company
1.02
2.15
1.24
1.6
0.72
0.47
1.37
1.02
0.57
1.56
1.02
EPS
0.4
0.77
0.44
0.57
0.26
0.17
0.48
0.36
0.2
0.55
0.36
Actual EPS
0.4
0.77
0.44
0.57
0.26
0.17
0.48
0.36
0.2
0.55
0.36
Adjusted EPS
0.4
0.77
0.44
0.57
0.26
0.17
0.48
0.36
0.2
0.55
0.36
Diluted EPS
0.4
0.77
0.44
0.57
0.26
0.17
0.48
0.36
0.2
0.55
0.36

Aarey Drugs & Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
349.35
354.74
300.09
348.42
492.68
418.96
395.62
473.94
472.27
Other Income
3.18
4.34
6.69
7.01
2.75
2.73
6.96
9.81
6.1
Total Income
352.53
359.08
306.78
355.43
495.43
421.69
402.58
483.76
478.37
Expenses
341.75
346.86
296.89
343.78
481.41
411.23
391.17
471.04
465.1
Operating Profit
7.6
7.88
3.2
4.64
11.27
7.73
4.45
2.9
7.17
Operating Profit Margin %
2.18%
2.22%
1.07%
1.33%
2.29%
1.85%
1.12%
0.61%
1.52%
Profit Before Interest, Tax and Depreciation
10.78
12.22
9.89
11.65
14.02
10.46
11.42
12.71
13.27
Interest
1.88
2.23
1.76
2.43
2
1.57
1.7
4.66
5
Depreciation
0.71
1.01
0.89
0.92
1.99
2.87
4.38
1.94
2.85
Profit Before Tax
8.19
8.98
7.24
8.3
10.03
6.02
5.34
6.11
5.42
Tax Paid
2.01
2.44
1.45
1.78
3.48
2.24
0.66
2.08
1.44
Profit After Tax
6.18
6.54
5.79
6.51
6.54
3.78
4.68
4.02
3.97
Total Net profit including share of profit / Loss from associate company
6.18
6.54
5.79
6.51
6.54
3.78
4.68
4.02
3.97
EPS
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
1.39
Actual EPS
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
1.39
Adjusted EPS
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
1.39
Diluted EPS
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.84
1.39

Aarey Drugs & Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
5.66
0.62
-20.35
0.69
2.86
5.48
0.5
-1.28
-2.99
10.3
Cash Flow from Investing Activities
-2.58
-4.97
-0.6
-1.23
-0.92
-2.88
-3.21
0.45
-1.7
-5.94
Cash Flow from Financing Activities
-1.63
3.74
23.3
-2.48
-1.81
-2.45
2.25
1.35
5.57
-4.48
Net Cash Flow
1.45
-0.58
2.35
-3.02
0.13
0.15
-0.46
0.51
0.89
-0.12

Aarey Drugs & Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Aug 2026
Promoters
50.04%
45.28%
45.44%
44.8%
44.8%
44.8%
44.8%
39.05%
37.71%
37.71%
42.79%
DII
0%
0%
0%
0%
0%
0%
0%
0%
1.62%
1.62%
1.49%
FII
0%
3.4%
2.75%
2.34%
2.34%
1.97%
1.13%
3.86%
4.18%
4.8%
4.41%
Public
46.13%
51.33%
51.81%
52.86%
52.86%
53.23%
54.07%
57.09%
56.49%
55.86%
51.3%
Total Outstanding Shares
2,53,84,684
2,80,54,303
2,79,54,303
2,83,54,303
2,83,54,303
2,83,54,303
2,83,54,303
2,83,54,303
2,83,54,303
2,83,54,303
3,08,74,303
Total Shareholders
15,269
16,179
16,676
16,288
16,257
15,796
14,897
14,063
14,188
13,478
13,480

Aarey Drugs & Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Aarey Drugs & Pharmaceuticals.

  • Aarey Drugs & Pharmaceuticals Ltd Earnings Results

    Aarey Drugs & Pharmaceuticals Ltd’s net profit fell -25.55% since last year same period to ₹1.02Cr in the Q1 2026-2027. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated -34.62% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Aarey Drugs & Pharmaceuticals Ltd Dividends November,2018

    In the quarter ending September 2018, Aarey Drugs & Pharmaceuticals Ltd has declared dividend of ₹0.10 per share on 30 Nov 2018 - translating a dividend yield of 0.10%.

    Read More about Dividends

Insights on Aarey Drugs & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 37.71% to 42.79% in Aug 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, AAREYDRUGS stock has moved up by 5.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Divis Laboratories Ltd has given 149.6% return, outperforming this stock by 21.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 42.8% return, outperforming this stock by 18.4%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 4.80% to 4.41% in Aug 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 55.86% to 51.30% in Aug 2026 quarter

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs Pharmaceuticals Ltd is one of the India's leading manufacturers and suppliers of pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, APIs, drugs, food colours and flavours. The company is equipped with a manufacturing unit located in Thane and has its corporate office in Mumbai. It was established in 1990 and is governed by central and state legislations that regulate the business. Their products meet the IP/ BP/ CP/ USP standards and are sourced from authentic vendors to guarantee quality and effectiveness. The company floated a public issue in 1993 of 27.5 lakh equity shares of Rs. 10 each and was listed on 3 stock exchanges. In 2009, the plant was upgraded to international standards. They also plan to manufacture new products and expand the existing production capacity of Metronidazole MTZ from 420 MT to 780 MT and Metronidazole Benzoate MBO from 120 MT to 240 MT. Aarey Drugs and Pharmaceuticals Ltd is a trusted manufacturer of pharmaceutical products and has been providing quality products since its establishment.

Revenue: ₹44.63Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1.02Cr as on June 2026 (Q1 FY27)
Listing date: 06 Aug, 2021
Chairperson Name: Mihir R Ghatalia
OrganisationAarey Drugs & Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOMihir R Ghatalia
E-voting on sharesClick here to vote

FAQs

What is Aarey Drugs & Pharmaceuticals share price today?

Aarey Drugs & Pharmaceuticals share price today stands at ₹104.08 as on at the close of the market. Aarey Drugs & Pharmaceuticals share today touched a day high of ₹105.7 and a low of ₹100.54.

What is the 52 week high and 52 week low range for Aarey Drugs & Pharmaceuticals share?

Aarey Drugs & Pharmaceuticals touched a 52 week high of ₹110 and a 52 week low of ₹50.31. Aarey Drugs & Pharmaceuticals share price today i.e. is closed at ₹104.08, which is -5.38% down from its 52 week high and 106.88% up from its 52 week low.

What is Aarey Drugs & Pharmaceuticals's market capitalisation today?

Aarey Drugs & Pharmaceuticals market capitalisation is ₹331.75 Cr as on .

How to buy Aarey Drugs & Pharmaceuticals shares?

To buy Aarey Drugs & Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AAREYDRUGS or Aarey Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aarey Drugs & Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aarey Drugs & Pharmaceuticals trading volume today?

Aarey Drugs & Pharmaceuticals trading volume is 1.52L as on . This means that 1.52L shares of Aarey Drugs & Pharmaceuticals were bought and sold on the stock market during today's trading session.